表 1.
患者一般信息及肿瘤特异多肽检测结果
Patient characters and specific tumor polypeptide information
| Serial number | Gender | Age/years | Clinical diagnosis and stage | Number of tumor specific polypeptides* | Polypeptide target organ# | Target cell△ |
| * number of specific tumor polypeptides detected and synthesized; # organ targeted after the specific tumor polypeptide detected in the patient’s peripheral blood were matched with the tumor specific polypeptide library; △ tumor cell line used in the killing activity experiment. NSCLC, non-small cell lung cancer; TNBC, triple-negative breast cancer. | ||||||
| 1 | Female | 58 | NSCLC stage Ⅳ | 8 | Lung | A549 |
| 2 | Male | 59 | Gastric cancer stage Ⅳ | 4 | Stomach | SGC-7901BGC-823 |
| 3 | Female | 57 | Gastric cancerstage Ⅳ | 6 | Stomach | SGC-7901BGC-823 |
| 4 | Male | 64 | Bladder cancerstage Ⅳ | 3 | Bladder | TCCSUP |
| 5 | Female | 73 | Mammary cancer stage Ⅳ | 5 | Breast | MCF-7 |
| 6 | Female | 56 | NSCLC stage Ⅳ | 6 | Lung | A549 |
| 7 | Male | 60 | NSCLC stage Ⅳ | 6 | Lung | A549 |
| 8 | Female | 46 | NSCLC stage Ⅳ | 8 | Lung | A549 |
| 9 | Female | 73 | Pancreatic cancer stage Ⅳ | 5 | Pancreas | CFPAC-1 |
| 10 | Female | 53 | TNBC stage Ⅳ | 6 | Breast | MDA-MB-453 |
| 11 | Male | 46 | Colonic metastasis of gastric cancer stage Ⅳ | 6 | Colon | HCT-116 |